Coldstream Capital Management Inc Athira Pharma, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,640 shares of ATHA stock, worth $712. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,640Holding current value
$712% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATHA
# of Institutions
61Shares Held
18.8MCall Options Held
17.2KPut Options Held
800-
Perceptive Advisors LLC New York, NY5.4MShares$1.46 Million0.11% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.2MShares$864,1800.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.54MShares$415,2360.0% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$403,0530.02% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$403,0530.87% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $10.2M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...